Literature DB >> 21979910

The role of catalytic iron in acute kidney injury.

Sudhir V Shah, Mohan M Rajapurkar, Radhakrishna Baliga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21979910     DOI： 10.2215/CJN.08340811

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  16 in total

Review 1.  Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention.

Authors:  Shreyak Sharma; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2019-09-25       Impact factor: 10.121

2.  Plasma catalytic iron, AKI, and death among critically ill patients.

Authors:  David E Leaf; Mohan Rajapurkar; Suhas S Lele; Banibrata Mukhopadhyay; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-04       Impact factor: 8.237

Review 3.  Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury.

Authors:  Sundararaman Swaminathan
Journal:  Nephron       Date:  2018-07-06       Impact factor: 2.847

Review 4.  Catalytic iron and acute kidney injury.

Authors:  David E Leaf; Dorine W Swinkels
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-17

Review 5.  Fibroblast growth factor 23 and acute kidney injury.

Authors:  Javier A Neyra; Orson W Moe; Ming Chang Hu
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

6.  Ferrotoxicity and its amelioration by endogenous vitamin D in experimental acute kidney injury.

Authors:  Chandrashekar Annamalai; Rajesh N Ganesh; Pragasam Viswanathan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-02

7.  Lipocalin 2 alleviates iron toxicity by facilitating hypoferremia of inflammation and limiting catalytic iron generation.

Authors:  Xia Xiao; Beng San Yeoh; Piu Saha; Rodrigo Aguilera Olvera; Vishal Singh; Matam Vijay-Kumar
Journal:  Biometals       Date:  2016-03-23       Impact factor: 2.949

8.  Urine catalytic iron and neutrophil gelatinase-associated lipocalin as companion early markers of acute kidney injury after cardiac surgery: a prospective pilot study.

Authors:  Krittapoom Akrawinthawong; Michael K Shaw; Joshua Kachner; Eugene O Apostolov; Alexie G Basnakian; Sudhir Shah; Jacqueline Tilak; Peter A McCullough
Journal:  Cardiorenal Med       Date:  2013-02-06       Impact factor: 2.041

9.  Parenteral versus oral iron therapy for adults and children with chronic kidney disease.

Authors:  Emma L O'Lone; Elisabeth M Hodson; Ionut Nistor; Davide Bolignano; Angela C Webster; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2019-02-21

Review 10.  Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.

Authors:  Stacey Ruiz; Pablo E Pergola; Richard A Zager; Nosratola D Vaziri
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.